FIELD: medicine, nephrology, phytotherapy. SUBSTANCE: invention relates to the development of medicinal agents as herb species that can be used for treatment of chronic pyelonephritis. Invention proposes the agent representing species of medicinal plants comprising Orthosiphon stamineus herb, common bear berry herb, glabrous licorice roots, pot-marigold flowers, matricary flowers and comprising additionally violet pensy (tricolor) herb, cowberry leaves, maize stigmas, common sandy immortelle flowers, sweet flag rhizome with roots, juniper fruits, flax seeds, common fennel fruits, common wormwood herb, common mother-of-thyme herb, gum-tree leaves, black elder flowers, knot-grass herb, linden flowers taken in the definite ratio. Intake of this agent provides the stable remission of patient state and the absence of adverse effects or toxic effect. EFFECT: valuable medicinal properties of agent. 2 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATMENT OF UROLITHIASIS | 2005 |
|
RU2281781C1 |
MEDICATION FOR TREATMENT OF PATIENTS WITH DRUG HEPATITIS | 2009 |
|
RU2419449C1 |
METHOD OF PREVENTION AND COMPLEX TREATMENT OF UROLITHIASIS AFTER DISTANT LITHOTRIPSY | 2010 |
|
RU2419427C1 |
SPECIES FOR PYELONEPHRITIS TREATMENT | 1998 |
|
RU2155054C2 |
TEA FOR TREATMENT OF CHRONIC PYELONEPHRITIS | 1992 |
|
RU2026079C1 |
AGENT FOR TREATMENT OF LIVER CIRRHOSIS ACCOMPANYING WITH ASCITIS | 2001 |
|
RU2224532C2 |
AGENT FOR TREATMENT OF CHRONIC VIRAL HEPATITIS B | 2000 |
|
RU2180228C1 |
MEDICATION FOR TREATING INTESTINAL DYSBIOSIS IN PATIENTS WITH CHRONIC CRYPTOGENIC HEPATITIS | 2009 |
|
RU2411955C1 |
UROLOGICAL SPECIES | 1996 |
|
RU2103003C1 |
HERBAL AGENT FOR TREATING AND PREVENTING URINARY STONE DISEASE | 2011 |
|
RU2445970C1 |
Authors
Dates
2004-02-27—Published
2001-06-04—Filed